Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic modelMOUTON, J. W; DEN HOLLANDER, J. G.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 5, pp 931-936, issn 0066-4804Article

Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusionMOUTON, J. W; MICHEL, M. F.Journal of antimicrobial chemotherapy (Print). 1991, Vol 28, Num 6, pp 911-918, issn 0305-7453Article

Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial PneumoniaMULLER, A. E; PUNT, N; MOUTON, J. W et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2512-2519, issn 0066-4804, 8 p.Article

Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapyVAN DER VELDEN, L. B. J; TROMP, M; BLEEKER-ROVERS, C. P et al.European journal of clinical microbiology & infectious diseases (Print). 2012, Vol 31, Num 7, pp 1561-1568, issn 0934-9723, 8 p.Article

Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulationMOUTON, J. W; VAN PEER, A; DE BEULE, K et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 12, pp 4096-4102, issn 0066-4804, 7 p.Article

Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolatesTE DORSTHORST, D. T. A; VERWEIJ, P. E; MEIS, J. F. G. M et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3341-3346, issn 0066-4804, 6 p.Article

Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infectionsBUIJK, S. L. C. E; GYSSENS, I. C; MOUTON, J. W et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 49, Num 1, pp 121-128, issn 0305-7453Article

Enzymatic method for inactivation of aminoglycosides during measurement of postantibiotic effectDEN HOLLANDER, J. G; MOUTON, J. W; BAKKER-WOUDENBERG, I. A. J. M et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 2, pp 488-490, issn 0066-4804Article

Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycinVAN'T VEEN, A; MOUTON, J. W; GOMMERS, D et al.Antimicrobial agents and chemotherapy. 1995, Vol 39, Num 2, pp 329-333, issn 0066-4804Article

Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosisMOUTON, J. W; DEN HOLLANDER, J. G; HORREVORTS, A. M et al.Journal of antimicrobial chemotherapy (Print). 1993, Vol 31, Num 6, pp 919-926, issn 0305-7453Article

Prevention of respiratory failure after hydrochloric acid aspiration by intratracheal surfactant instillation in ratsEIJKING, E. P; GOMMERS, D; SO, K. L et al.Anesthesia and analgesia. 1993, Vol 76, Num 3, pp 472-477, issn 0003-2999Article

Evaluation of clearview and magic lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimensKLUYTMANS, J. A. J. W; GOESSENS, W. H. F; MOUTON, J. W et al.Journal of clinical microbiology (Print). 1993, Vol 31, Num 12, pp 3204-3210, issn 0095-1137Article

Abnormal pharmacokinetics : the need for monitoringHORREVORTS, A. M; MOUTON, J. W.European journal of clinical microbiology & infectious diseases (Print). 1993, Vol 12, Num 1, pp S58-S60, issn 0934-9723, SUPArticle

Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment optionsHASSING, R.-J; GOESSENS, W. H. F; MEVIUS, D. J et al.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 10, pp 1295-1301, issn 0934-9723, 7 p.Article

Concentration-dependency of β-lactam-induced filament formation in Gram-negative bacteriaBUIJS, J; DOFFERHOFF, A. S. M; MOUTON, J. W et al.Clinical microbiology and infection. 2008, Vol 14, Num 4, pp 344-349, issn 1198-743X, 6 p.Article

Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infectionGOESSENS, W. H. F; MOUTON, J. W; TEN KATE, M. T et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 3, pp 507-516, issn 0305-7453, 10 p.Article

Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesTE DORSTHORST, D. T. A; VERWEIJ, P. E; MEIS, J. F. G. M et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 3, pp 702-707, issn 0066-4804Article

Use of pharmacodynamic indices to predict efficacy of combination therapy in vivoMOUTON, J. W; VAN OGTROP, M. L; ANDES, D et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 10, pp 2473-2478, issn 0066-4804Article

Lung clearance of intratracheally instilled ^99mTc-tobramycin using pulmonary surfactant as vehicleVAN'T VEEN, A; GOMMERS, D; VERBRUGGE, S. J. C et al.British journal of pharmacology. 1999, Vol 126, Num 5, pp 1091-1096, issn 0007-1188Article

Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infectionsDE MARIE, S; VANDENBERGH, M. F. Q; BUIJK, S. L. C. E et al.Intensive care medicine (Print). 1998, Vol 24, Num 4, pp 343-346, issn 0342-4642Article

Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an In vitro pharmacokinetic modelDEN HOLLANDER, J. G; HORREVORTS, A. M; VAN GOOR, M.-L. P. J et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 1, pp 95-100, issn 0066-4804Article

Patient-to-patient spread of a single strain of Corynebacterium striatum causing infections in a surgical intensive care unitBRANDENBURG, A. H; VAN BELKUM, A; VAN PELT, C et al.Journal of clinical microbiology (Print). 1996, Vol 34, Num 9, pp 2089-2094, issn 0095-1137Article

ΔAPACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defenseYZERMAN, E. P. F; BOELENS, H. A. M; TJHIE, J. H. T et al.The Journal of infectious diseases. 1996, Vol 173, Num 4, pp 914-919, issn 0022-1899Article

Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureusKLUYTMANS, J. A. J. W; MOUTON, J. W; VANDENBERGH, M. F. Q et al.Infection control and hospital epidemiology. 1996, Vol 17, Num 12, pp 780-785, issn 0899-823XArticle

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteersMOUTON, J. W; HOREVORTS, A. M; MULDER, P. G. H et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 12, pp 2307-2311, issn 0066-4804, 5 p.Article